An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

计划入组 30 人 · 首次发布于 2021 年 8 月 26 日

Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC

首次发布于 2015 年 4 月 2 日

Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

计划入组 17 人 · 首次发布于 2015 年 4 月 14 日

drug delivery system

OLipHEX delivery system

Pennkinetic Delivery System

iVeena Delivery Systems, Inc.

United States

Cristal Delivery B.V.

Netherlands

Aveva Drug Delivery Systems, Inc.

United States

New Liver-Directed Treatment Shows Promising Results for Metastatic Uveal Melanoma

Subgroup Analysis of Phase 3 FOCUS Study Reveals Optimal Patient Selection for Melphalan/Hepatic Delivery System in Uveal Melanoma

FDA Clears Delcath's HEPZATO for Phase 2 Trial in Liver-Dominant Metastatic Breast Cancer